<DOC>
	<DOC>NCT02822053</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and efficacy of ultrasonography (US) -guided laser ablation liver, kidney, pancreas, lung and retroperitoneal tumors, the investigators used preoperative and postoperative US/CEUS/CT/MRI to assess lesions, and laboratory tests including the tumor markers to evaluate the general condition of patients. Intraoperative US/CEUS/CT would be applied to monitor ablation lesions.</brief_summary>
	<brief_title>Effectivity and Safety of Ultrasound-guided Percutaneously Laser Ablation for Refractory Neoplasms</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Patients with small hepatocellular carcinoma (single or multiple nodules of less than 3 cm in diameter), Patients with ChildPugh A/B, Patients with PLT ≥ 50*10E9/L and PT ≤ 20s. Patients with blood coagulation dysfunction, ChildPugh ≥3, severe cardiopulmonary disease, intolerant anesthesia and upper gastrointestinal bleeding in shock.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Ultrasonography-guided Laser Ablation</keyword>
</DOC>